News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Investment Banking

Evercore lands role on $10.1bn Nestlé deal

Win is a boost for Evercore and comes as boutiques’ steady march onto larger rivals’ turf has paused in 2019

Nestlé Skin Health owns Galderma, a pharmaceutical company specialising in dermatological treatments, including Dysport (botox), which is being demonstrated at an event
Nestlé Skin Health owns Galderma, a pharmaceutical company specialising in dermatological treatments, including Dysport (botox), which is being demonstrated at an event Photo: Cooper Neill/Getty Images

Evercore has landed a role advising Nestlé on the $10.1bn sale of its Skin Health business to a consortium of private equity firms, a boost to the company after a difficult first quarter for boutique investment banks.

The boutique bank is advising Nestlé alongside Credit Suisse on the transaction, with a group of private equity firms led by EQT and a subsidiary of the Abu Dhabi Investment Authority winning the fiercely contested deal.

WSJ Logo